Physician profile
David E Fish
NPI 1356424741
$26,320.58
in general payments reported to CMS, 2019-2025
29 companies · $3,939 in 2025
The $3,939 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,748 · 2020: $2,506 · 2021: $2,293 · 2022: $4,584 · 2023: $4,610 · 2024: $3,640 · 2025: $3,939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $332 · Education: $41.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,816.09 |
| Travel and Lodging | $331.61 |
| Education | $41.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,193.42 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $5,990.27 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Spr Therapeutics, INC | $1,518.00 | 2019-2025 | Sprint Pns System |
| Stimwave Technologies Incorporated | $1,398.83 | 2019-2022 | |
| Abbott Laboratories | $1,314.63 | 2019-2024 | Proclaim, Eterna |
| Medtronic USA, INC. | $1,184.20 | 2019-2020 | |
| Nalu Medical, INC. | $874.32 | 2020-2023 | Nalu Neurostimulation System |
| Integra Lifesciences Corporation | $748.58 | 2019-2022 | |
| Vertiflex, INC. | $526.05 | 2019 | |
| Innovation Technologies INC | $455.46 | 2021-2024 | Irrisept |
| Depuy Synthes Sales INC. | $437.53 | 2019 | |
| Stryker Corporation | $429.98 | 2021-2025 | Mild Device Kit, Omnicurve, Optablate |
| Merz Pharmaceuticals, LLC | $410.09 | 2021-2022 | |
| Innovasis INC | $407.87 | 2023 | |
| Allergan, INC. | $309.54 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $308.93 | 2023-2024 | Prospera, Biotronik |
| Curonix LLC | $291.83 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $268.02 | 2019-2021 | |
| Merz North America, INC. | $262.53 | 2019-2020 | |
| Avanos Medical | $235.60 | 2020-2021 | |
| Medacta USA, INC. | $146.87 | 2022 | |
| Cala Health, INC. | $106.58 | 2022 | |
| Axonics, INC. | $94.30 | 2020-2021 | |
| Spinal Simplicity, LLC | $90.84 | 2021 | |
| Corelink, LLC | $89.54 | 2020 | |
| Abbvie INC. | $84.81 | 2023 | |
| Team_makena_llc | $84.73 | 2019 | |
| Vertos Medical, INC. | $42.59 | 2019 | |
| Inari Medical, INC. | $14.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.